They have demonstrated that vaspin-transgenic mice are protected against diet-induced obesity, glucose tolerance impairment, and fatty liver, whereas vaspin-deficient mice develop glucose intolerance due to upregulation of the endoplasmic reticulum (ER) stress markers. Here, SERPINA12 is linked to Glucose intolerance.